BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,712,086 | +4.6% | 241,820 | +4.0% | 0.04% | -17.3% |
Q2 2023 | $1,636,540 | -13.1% | 232,463 | +3.0% | 0.05% | -10.3% |
Q1 2023 | $1,882,872 | -99.9% | 225,764 | +4.4% | 0.06% | +11.5% |
Q3 2022 | $2,726,000,000 | +9.0% | 216,327 | -8.5% | 0.05% | +40.5% |
Q2 2022 | $2,500,000,000 | – | 236,327 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |